Refferences
- Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet. 2015;385(9981):1975–1982. doi:https://doi.org/10.1016/S0140-6736(14)61601-9.
- Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395(10225):709–733. doi:https://doi.org/10.1016/S0140-6736(20)30045-3.
- Mirzakhani M, Shahbazi M, Akbari R, et al. Reduced CD4+ CD25++ CD45RA − Foxp3hi activated regulatory T cells and its association with acute rejection in patients with kidney transplantation. Transplant Immunology. 2020;60:101290. doi:https://doi.org/10.1016/j.trim.2020.101290.
- Mirzakhani M, Shahbazi M, Akbari R, Dedinská I, Nemati E, Mohammadnia-Afrouzi M. Soluble CD30, the immune response, and acute rejection in human kidney transplantation: a systematic review and meta-analysis. Front Immunol. 2020;11:295. doi:https://doi.org/10.3389/fimmu.2020.00295.
- Shahi A, Salehi S, Afzali S, et al. Evaluation of thymic output and regulatory T cells in kidney transplant recipients with chronic antibody-mediated rejection. BioMed Res Int. 2021;2021:1–12. doi:https://doi.org/10.1155/2021/6627909.
- Salehi S, Shahi A, Afzali S, Keshtkar AA, et al. Transitional immature regulatory B cells and regulatory cytokines can discriminate chronic antibody-mediated rejection from stable graft function. Int Immunopharmacol. 2020;86:106750. doi:https://doi.org/10.1016/j.intimp.2020.106750.
- Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010;363(15):1451–1462. doi:https://doi.org/10.1056/NEJMra0902927.
- Mirzakhani M, Mohammadnia-Afrouzi M, Shahbazi M, Mirhosseini SA, Hosseini HM, Amani J. The exosome as a novel predictive/diagnostic biomarker of rejection in the field of transplantation. Clinical Immunology. 2019;203:134–141. doi:https://doi.org/10.1016/j.clim.2019.04.010.
- Wekerle T, Segev D, Lechler R, Oberbauer R. Strategies for long-term preservation of kidney graft function. The Lancet. 2017;389(10084):2152–2162. doi:https://doi.org/10.1016/S0140-6736(17)31283-7.
- Mirzakhani M, Shahbazi M, Oliaei F, Mohammadnia‐Afrouzi M. Immunological biomarkers of tolerance in human kidney transplantation: an updated literature review. J Cell Physiol. 2019;234(5):5762–5774. doi:https://doi.org/10.1002/jcp.27480.
- Kreisel D, Sugimoto S, Zhu J, et al. Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood. 2011;118(23):6172–6182. doi:https://doi.org/10.1182/blood-2011-04-347823.
- Benichou G, Tonsho M, Tocco G, Nadazdin O, Madsen JC. Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immun. 2012;3:73. doi:https://doi.org/10.3389/fimmu.2012.00073.
- Braza MS, van Leent MM, Lameijer M, Sanchez-Gaytan BL, et al. Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance. Immunity. 2018;49(5):819–828.e816. doi:https://doi.org/10.1016/j.immuni.2018.09.008.
- Shahbazi M, Smailnejad-Ganji K, Mirzakhani M, Mohammadnia-Afrouzi M, Akbari R. Immune response as a mechanism of the initiation and progression of chronic kidney disease: from the inflammation to immunosenescence. Iran J Kidney Dis. 2019;13(5):283–299.
- Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014;14(3):166–180. doi:https://doi.org/10.1038/nri3607.
- Morelli AE, Larregina AT. Concise review: mechanisms behind apoptotic cell‐based therapies against transplant rejection and graft versus host disease. Stem Cells. 2016;34(5):1142–1150. doi:https://doi.org/10.1002/stem.2326.
- Ochando J, Ordikhani F, Boros P, Jordan S. The innate immune response to allotransplants: mechanisms and therapeutic potentials. Cell Mol Immunol. 2019;16(4):350–356. doi:https://doi.org/10.1038/s41423-019-0216-2.
- Braza F, Brouard S, Chadban S, Goldstein DR. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol. 2016;12(5):281–290. doi:https://doi.org/10.1038/nrneph.2016.41.
- Chong AS, Alegre M-L. The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol. 2012;12(6):459–471. doi:https://doi.org/10.1038/nri3215.
- Li W, Feng G, Gauthier JM, et al. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation. J Clin Invest. 2019;129(6):2293–2304. doi:https://doi.org/10.1172/JCI126428.
- Leventhal JS, Schröppel B. Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int. 2012;81(9):826–832. doi:https://doi.org/10.1038/ki.2011.498.
- Zhuang Q, Lakkis FG. Dendritic cells and innate immunity in kidney transplantation. Kidney International. 2015;87(4):712–718. doi:https://doi.org/10.1038/ki.2014.430.
- Scozzi D, Ibrahim M, Menna C, Krupnick AS, Kreisel D, Gelman AE. The role of neutrophils in transplanted organs. Am J Transplant. 2017;17(2):328–335. doi:https://doi.org/10.1111/ajt.13940.
- Ochando J, Fayad ZA, Madsen JC, Netea MG, Mulder WJ. Trained immunity in organ transplantation. Am J Transplant. 2020;20(1):10–18. doi:https://doi.org/10.1111/ajt.15620.
- Saeed S, Quintin J, Kerstens HH, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 2014;345(6204):1251086. doi:https://doi.org/10.1126/science.1251086.
- Lin Y, Vandeputte M, Waer M. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol. 1997;158(12):5658–5667.
- Fox A, Mountford J, Braakhuis A, Harrison LC. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol. 2001;166(3):2133–2140. doi:https://doi.org/10.4049/jimmunol.166.3.2133.
- Liu W, Xiao X, Demirci G, Madsen J, Li XC. Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms. JI. 2012;188(6):2703–2711. doi:https://doi.org/10.4049/jimmunol.1102997.
- Oberbarnscheidt MH, Zeng Q, Li Q, et al. Non-self recognition by monocytes initiates allograft rejection. J Clin Invest. 2014;124(8):3579–3589. doi:https://doi.org/10.1172/JCI74370.
- Oberbarnscheidt MH, Lakkis FG. Innate allorecognition. Immunol Rev. 2014;258(1):145–149. doi:https://doi.org/10.1111/imr.12153.
- Chu Z, Sun C, Sun L, et al. Primed macrophages directly and specifically reject allografts. Cell Mol Immunol. 2020;17(3):237–246. doi:https://doi.org/10.1038/s41423-019-0226-0.
- Lakkis FG, Li XC. Innate allorecognition by monocytic cells and its role in graft rejection. Am J Transplant. 2018;18(2):289–292. doi:https://doi.org/10.1111/ajt.14436.
- Zhao D, Abou-Daya KI, Dai H, Oberbarnscheidt MH, Li XC, Lakkis FG. Innate allorecognition and memory in transplantation. Front Immunol. 2020;11:918. doi:https://doi.org/10.3389/fimmu.2020.00918.
- Dai H, Friday AJ, Abou-Daya KI, et al. Donor SIRPα polymorphism modulates the innate immune response to allogeneic grafts. Sci Immunol. 2017;2(12):eaam6202. doi:https://doi.org/10.1126/sciimmunol.aam6202.
- Takai T. Paired immunoglobulin‐like receptors and their MHC class I recognition. Immunology. 2005;115(4):433–440. doi:https://doi.org/10.1111/j.1365-2567.2005.02177.x.
- Domínguez-Andrés J, Netea MG. The specifics of innate immune memory. Science. 2020;368(6495):1052–1053. doi:https://doi.org/10.1126/science.abc2660.
- Bird L. Myeloid memory to non-self. Nat Rev Immunol. 2020;20(8):460–461. doi:https://doi.org/10.1038/s41577-020-0375-5.
- Dai H, Lan P, Zhao D, et al. PIRs mediate innate myeloid cell memory to nonself MHC molecules. Science. 2020;368(6495):1122–1127. doi:https://doi.org/10.1126/science.aax4040.